Novel HBV mutations and their value in predicting efficacy of conventional interferon

MLA

Ke-Wei Sun, et al. “Novel HBV Mutations and Their Value in Predicting Efficacy of Conventional Interferon.” Hepatobiliary & Pancreatic Diseases International, vol. 16, Apr. 2017, pp. 189–96. EBSCOhost, https://doi.org/10.1016/s1499-3872(16)60184-4.

APA

Ke-Wei Sun, Xiaoyu Fu, Deming Tan, Guo-Zhong Gong, Huan-Yu Gong, Ling Wang, Daxian Wu, & Juan Wu. (2017). Novel HBV mutations and their value in predicting efficacy of conventional interferon. Hepatobiliary & Pancreatic Diseases International, 16, 189–196. https://doi.org/10.1016/s1499-3872(16)60184-4

Chicago

Ke-Wei Sun, Xiaoyu Fu, Deming Tan, Guo-Zhong Gong, Huan-Yu Gong, Ling Wang, Daxian Wu, and Juan Wu. 2017. “Novel HBV Mutations and Their Value in Predicting Efficacy of Conventional Interferon.” Hepatobiliary & Pancreatic Diseases International 16 (April): 189–96. doi:10.1016/s1499-3872(16)60184-4.